Patrick Tricoli focused his research in academia and industry, in both France and US, before joining Synthélabo Recherche in 1991.
From 1996 to 2007, at Synthélabo Coporate, Sanofi-Synthélabo and Sanofi-Aventis he developed external public financing, collaborative R&D program and a team managing up to 40 collaborations. In 2007 he developed external innovation as Global Deputy Head of Partnering and Innovation R&D. In March 2009 he became head of External Innovation Europe for Sanofi then developed international scouting and corporate development strategy for Bio Business conferences in Europe, Asia Pacific and in the US.
Since 2014 he serves as CEO of Nanobiotix Corp, the Nanobiotix US affiliate. He serves also as a Foreign Trade Advisor to the French government.
Patrick is a Pharm D, Master in Pharmacology and Pharmacokinetic and Executive MBA from ESCP Europe.